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I read with great interest the study performed by van Rhijn BD et al. “Histological Response to 
Fluticasone Propionate in Patients With Eosinophilic Esophagitis Is Associated With Improved 
Functional Esophageal Mucosal Integrity” (6). The rise in the prevalence of eosinophilic 
esophagitis (EoE) is potentiating the basic research on the pathophysiology of this disease as is 
shown by the increasing amount of publications during the last 5 years. More recently, the 
impaired epithelial integrity present in these patients has also been suggested as a key player in 
EoE.    
Authors of the present study suggest that Fluticasone Propionate treatment decreases 
eosinophilic inflammation and improves the esophageal mucosal barrier integrity in adult EoE 
patients. Epithelial integrity was measured in vivo, but also in vitro with the gold standard Ussing 
chamber technique.  
 
Several relevant concerns regarding in vitro measurements rose after reading the present study.  
1- It is very difficult to believe that authors were able to properly mount and study all the taken 
biopsies in an adaptor with an opening of 2 mm diameter, even using a high capacity Jumbo 
forceps.  
 
2- Compared with data using the same equipment and size of the adaptor from the very 
experienced and pioneer group of Prof. Roy Orlando, the transepithelial electrical resistance 
(TEER) values currently reported in patients, but also from healthy volunteers, are extremely 
low: at least half the magnitude (2-4). Recently, Sherrill et al. published that EoE patients with 
active disease have a TEER of 80 Ωxcm2 (N=9). The healthy volunteer population in this study has 
a TEER of 210 Ωxcm2 (N=6). The same group reported even values of more than 300 Ωxcm2 in 
two  larger population of healthy volunteers (N=13 and N=25)(2; 4). TEER values of the present 
study are 34 Ωxcm2 (N=10) and 116 Ωxcm2 (N=11) for patients and the control group 
respectively.                              
 3- Even more striking is that the flux of fluorescein in the luminal to basolateral direction is 
extremely high, not only in patients with EoE but also in healthy volunteers, showing that the 
biopsies are not properly placed and completely covering the opening of the adaptor. The flux 
(J) of a probe is calculated by J= (Δc x Vch)/ (Δt x A) and is expressed as nmol/h/cm2.  Δc is the 
concentration difference of the probe in the acceptor chamber at time t1 and t2 , Δt is the time 
difference t1-t2 , Vch is the volume of the hemi-chamber and A is the area of the specimen. Due 
to the concentration dependence, fluxes from different studies cannot be compared when the 
concentration of the probe in the donor chamber is different. To make this possible the apparent 
permeability (Papp) is used and it origins from the division of the flux J by the concentration of 
the probe in the donor chamber, the unit is cm/s. The Papp for the healthy control group of the 
present study, taking and average flux of 500 nmol/h/cm2, is 105.2 x 10-6 cm/s. This is much 
higher than the values calculated from the control group of the study by Jovov et al (2). In this 
study authors found that the concentration of fluorescein in the basolateral side was in that 
group 0.01% of the concentration added at the luminal side (1 mM or 0.37 mg/mL), based on 
the formulas explained before the J is 8 nmol/h/cm2 and the Papp is 2.2 x 10-6 cm/s. In another 
study by Bjorkman et al., authors directly reported that the  Papp  of the esophageal epithelium 
is 0.2 x 10-6 cm/s (1) by using an A of 0.29 cm2. By using an adaptor with an A of 0.017 cm2, we 
found in one of our cohorts of healthy volunteers (N=12) that average TEER after 1 h was around 
250 Ωxcm2 , the J was 1 nmol/h/cm2 and the Papp  was 0.1 x 10-6 cm/s (unpublished data). It is 
very remarkable that the Papp for fluorescein reported in the present study in healthy volunteers 
is very high and never achieved in a simple epithelium from other segments of the 
gastrointestinal tract (1; 5). Moreover, it is hard to believe that an increase of 30 Ωxcm2 after 
fluticasone treatment is able to normalize the flux of fluorescein, as is shown by the similar 
values observed in the historic cohort (693 nmol/h/cm2 (0–2,589) vs. 345 nmol/h/cm2 (0–1451), 
p=0.53) . TEER after treatment in EoE patients still is half, when compared with the historic 
cohort (116 Ωxcm2 vs. 64 Ωxcm2). 
 
Based on these arguments, I am confident to state that the biopsies assessed in the present 
study are not well placed in the adaptor, as shown by the extremely high Papp and the low TEER. 
Unfortunately, authors do not mention which criteria they use to assure that biopsies are viable 
and well mounted. This makes the interpretation of the results very difficult. They might see a 
significant difference in their results, however, badly mounted biopsies cannot be used to make 
scientifically correct conclusions. Experienced researchers in this type of measurements know 
all very well that not all the biopsies initially studied can be included.  
 I would like to conclude saying that I strongly encourage the authors of the present study and 
eventually researchers of other research groups to assure correct measurements of epithelial 
integrity with the golden Standard Ussing chambers technique, when using endoscopic biopsies 
independently from the segment of the gastrointestinal tract or other tissues. 
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